dissolution method development for generic drugs (24/28) generic drugs forum 2017
Published 4 years ago • 5.9K plays • Length 15:23Download video MP4
Download video MP3
Similar videos
-
20:47
generic drug product quality review (23/28) generic drugs forum 2017
-
17:35
fda’s bioequivalence recommendations for generic drugs (16/28) generic drugs forum 2017
-
16:23
manufacturing process and controls (25/28) generic drugs forum 2017
-
21:57
biopharmaceutics risk assessment to guide dissolution method development for solid oral dosage forms
-
17:27
opq integrated quality assessment (iqa) process (20/28) generic drugs forum 2017
-
16:19
referencing approved drug products in anda submissions (9of28) generic drugs forum – apr. 3-4, 2019
-
19:24
anda policy and regulatory considerations prior to filing (12/28) generic drugs forum 2017
-
15:47
dissolution method development for immediate release (ir) drug product
-
31:34
anda performance/operations update (3/28) generic drugs forum 2017
-
35:21
decrease rtr, ir, and cr due to dissolution deficiencies (21of28) gdf – apr. 3-4, 2019
-
20:14
generic drug product quality assessment (22of27) generic drugs forum 2018
-
10:36
questions and answers (28of28) generic drugs forum – apr. 3-4, 2019
-
55:12
ich q12 guidance and emerging technology program (11of16) generic drugs forum 2020
-
14:24
assessment tips (17of28) generic drugs forum – apr. 3-4, 2019
-
15:46
questions and answers (15of28) generic drugs forum – apr. 3-4, 2019
-
19:35
update on technical rejection criteria for study data (14of28) generic drugs forum – apr. 3-4, 2019
-
23:55
questions and answers (23of28) generic drugs forum – apr. 3-4, 2019
-
30:26
best practices for conducting bioequivalence studies (16of27) generic drugs forum 2018